The Company has found a competitive advantage working with Dr. Steven Laviolette (neuroscientist), a scientific veteran with over 14 years of research experience in the field of mental health and cannabinoids and he oversees a dedicated team of 13 scientists at Western University.
Dr. Laviolette’s mandate is to conduct research and pre-clinical trials to develop safe, healthy products that utilize cannabis and hemp molecules, and botanical compounds, while blocking the negative psychiatric side-effects. All selected compounds are natural and pharmaceutical grade (non-synthetic). This partnership gives CanaQuest a tremendous product development resource in the medical cannabis sector. The completed pre-clinical trials at the Western University lab have demonstrated amazing results.
As well, CanaQuest has signed agreements with partners and collaborators in Canada, USA and globally to ensure proper supply, processing, packaging and distribution.
Contacts & Networking
Power of our Health Canada License
Global growth with minimal capital expenditures
- No infrastructure
- No large growing or production facilities
- No costly equipment and scheduled maintenance
- No compliance with SOP to satisfy regulations